CONTACT: Gerry Gould VP-Investor Relations Tel. (781) ... ... ... <a href="http://www.bio-medicine.org/inc/biomed/medicine-technology.asp">http://www.bio-medicine.org/inc/biomed/medicine-technology.asp</a> http://feeds.bio-medicine.org/latest-medical-technologyDate:4/29/2012 l; transaction costs; actual or contingent liabilities; and other risks and uncertainties discussed in Haemonetics' filings with the U.S. Securities and Exchange Commission, including the Risk Factors